MycoMedica Life Sciences (MMLS) is dedicated to developing and delivering fungi-based therapeutic drugs to prevent and treat psychiatric and neurological disorders. Building on more than four decades of research by world-renowned mycologist Paul Stamets, MycoMedica’s breakthrough innovation, the Stamets Stack uses a novel combination of ingredients – not found together in nature – to unlock the potential effectiveness of psilocybin in the prevention and treatment of psychiatric and neurological disorders.